Podcast appearances and mentions of jake sherkow

Hank Greely, Patti Zettler, Jake Sherkow, and Malia McPherson discuss Right to Try laws, Heart Valve Patents, GMO Labelling, and Neuroscience and Johnny Cash.

Hank Greely, Patti Zettler, and Jake Sherkow discuss the Zohydro litigation, Ebola, Biosimilars, and the Ninth Circuit's recent en banc decision.

Hank Greely, Patti Zettler, and Jake Sherkow discuss the Myriad Genetics case, the inaccuracies of whole genome sequencing and Alzheimer's testing, tooth whitening and antitrust, and the ethics of mitochondrial transfer.

Ryan Abbott from Southwestern discusses his recent work with Jake Sherkow and Patti Zettler.

Hank Greely, Patti Zettler, and Jake Sherkow discuss de-extinction, chronic traumatic encephalopathy, the hollowing out of the NIH, the Maryland v. King case, gene patenting, and FDA's regulation of genetic testing.

Hank Greely, Patti Zettler, and Jake Sherkow discuss Oklahoma abortion statutes, donor siblings and insurance coverage, and prenatal genetic test patents.

Hank Greely, Patti Zettler, and Jake Sherkow discuss exceptions to the Genetic Non-discrimination Act, acetaminophen and liver damage, football and concussions, and recent Nobel prize winners.

Dan Burk from UC Irvine discusses his recent work with Jake Sherkow.

Hank Greely, Patti Zettler, and Jake Sherkow discuss a lawsuit to remove a blood sample from the federal government's possession, synthetic drugs in New Zealand, and the veto of a California Bill that would legalize a stipend for human eggs donated for research purposes.

Hank Greely and Jake Sherkow discuss recent Supreme Court Cases.

Hank Greely, Jake Sherkow,and Matt Lamkin discuss a recent Supreme Court decision involving Monsanto, the MERS virus, attempts to patent the gut microbiome, and de-extinction.

Hank Greely, Amanda Rubin, Roland Nadler, and Jake Sherkow discuss the brain map initiative, transcranial direct current stimulation, the Amgen v. Retirement Plan case, and mice with human neurons.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss race issues in genetic testing, the myth of anonymity in genetic donation, and the prospects for "bringing back" the Neanderthal.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss the Supreme Court cases Bowman v. Monsanto, Mutual Pharmaceutical v. Bartlett, FTC v. Watson, Maryland v. King, and Association for Molecular Pathology v. Myriad.

Hank Greely discusses recent attempts to introduce FMRI-based lie detection as courtroom evidence; Jake Sherkow analyzes a recent appellate court decision about "pay to delay" settlements between name brand drug companies and generic manufacturers; and Matt Lamkin argues against proposals to expand regulatory oversight of "enhancement" technologies. (September 13, 2012)

Hank Greely, Jake Sherkow, and Matt Lamkin discuss DNA collection statutes, children with three parents, gene therapy for clinical use, and how the biosciences are implicated in the election.

Hank Greely and Jake Sherkow discuss mouse eggs and cloning, recent Nobel Prize winners, the fungal meningitis outbreak, bioscience fiction, and exoplanets.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss fMRI lie-detection services, pay-to-delay settlements between branded pharmaceutical and generics companies, and the arguments against increased regulation of enhancement technologies.